Kubo, Makoto http://orcid.org/0000-0001-6000-8731
Kawai, Masaaki
Kumamaru, Hiraku
Miyata, Hiroaki
Tamura, Kenji
Yoshida, Masayuki
Ogo, Etsuyo
Nagahashi, Masayuki
Asaga, Sota
Kojima, Yasuyuki
Kadoya, Takayuki
Aogi, Kenjiro
Niikura, Naoki
Miyashita, Minoru
Iijima, Kotaro
Hayashi, Naoki
Yamamoto, Yutaka
Imoto, Shigeru
Jinno, Hiromitsu
Funding for this research was provided by:
Japanese Breast Cancer Society
Article History
Received: 12 August 2019
Accepted: 19 August 2019
First Online: 26 August 2019
Compliance with ethical standards
:
: Each author of NH and YY has received honorariums as a speaker or consultant/advisory role from Company Chugai Pharmaceutical Co. (Tokyo, Japan). The other authors declare that they have no conflicts of interest.
: This article does not contain any studies with animals performed by any of the authors. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study. The study was approved by the Research Ethics Committee of NCD/JBCS and Kyushu University Hospital (No. 30-450).